split ceo/chair

Give up board chairmanship? No thanks, US big pharma CEOs say | BioPharma Dive

Posted by ValueEdge blog staff on

VEA Vice Chair Nell Minow is quoted in this article about pharma companies’ reluctance to split the CEO and chair roles.

“You don’t get to be a CEO by wanting to report to anybody, which is why it’s important to have somebody overseeing [the CEO],” said Nell Minow, a corporate governance expert who serves as vice chair of the institutional investment consulting group ValueEdge Advisors.

via Give up board chairmanship? No thanks, US big pharma CEOs say | BioPharma Dive

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Google photo

You are commenting using your Google account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s